Financial Assistance Resources
RESOURCES
-
Boehringer Ingelheim created a resource designed to educate patients on the recent Medicare Part D changes. Click here to learn more.
​​
-
Advanced Accelerator Applications (AAA) has a patient support program to deliver assistance for eligible patients. Click here to learn more.
​
-
GoodRx is a free website and mobile app that compares prescription drug price and provides drug coupons for discounts on medications.
-
IpsenCares provides coverage, access, reimbursement, and education support for lanreotide (Somatuline Depot). Go to ipsencares.com or call 866-435-5677.
-
Novartis Patient Assistance Foundation (NPAF) provides access to Novartis medications including Afinitor (everolimus), Lutathera (lutetium Lu177 dotatate), and Sandostatin LAR (octreotide acetate). Click here to check eligibility and application instructions. For the Novartis universal co-pay program, go to Copay.NovartisOncology.com or call 877-577-7756. Novartis - Patient Financial Assistance & Government Insurance
​
-
TerSera offers co-pay assistance for Xermelo (telotristat ethyl), a prescription pill, used along with somatostatin analog (SSA) therapy for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy. For more information, go to copay.xermelo.com.
​​
-
Patient Advocate Foundation provides co-pay relief and financial aid.
-
Triage Cancer offers a lengthy list of financial resources including travel expenses and lodging, transportation, young adult specific assistance, prescription drugs, and much more.
​​​
​
​
​
​
​
-
The CureNET Project is offering a $5,000 patient grant for any NET patient that is 18 years or older. It is meant to help cover medical costs, travel to see a NET specialist, pay bills, allow families to spend time together - whatever the recipient feels necessary. The submission deadline is October 15, 2023. Click here for more information.
​
-
The HealthWell Foundation®, an independent non-profit charitable organization that provides financial assistance for underinsured Americans has launched a new fund to assist individuals living with neuroendocrine tumors. Through the fund, HealthWell will provide up to $15,000 in medication copayment or insurance premium assistance to patients for prescription drugs and biologics for the treatment of their disease. Eligible patients must have household incomes up to 500 percent of the federal poverty level. To determine eligibility and apply for assistance, visit HealthWell's Neuroendocrine Tumors Fund page. Note that all new fund openings and fund re-openings occur at 11:00 a.m. Eastern Daylight Time (8:00 a.m. Pacific) Monday through Friday. For more information go to: https://www.healthwellfoundation.org/fund/neuroendocrine-tumors/.
​